Sfoglia per Rivista BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY
Can IL-23 be a good target for ulcerative colitis?
2018-01-01 Allocca, M; Furfaro, F; Fiorino, G; Gilardi, D; D'Alessio, S; Danese, S
Colorectal cancer prevention in patients with ulcerative colitis
2018-01-01 Lopez, A; Pouillon, L; Beaugerie, L; Danese, S; Peyrin-Biroulet, L
Endoscopic ultrasound guided biliary interventions
2022-01-01 Dell'Anna, Giuseppe; Ogura, Takeshi; Vanella, Giuseppe; Nishikawa, Hiroki; Lakhtakia, Sundeep; Arcidiacono, Paolo Giorgio
Evolving strategies and goals of treatment in ulcerative colitis
2018-01-01 Allocca, M; Peyrin-Biroulet, L; Danese, S
Introduction
2022-01-01 Arcidiacono, Paolo Giorgio; Santo, Erwin
JAK inhibitors: Novel developments in management of ulcerative colitis
2018-01-01 Fiorino, G; D'Amico, F; Italia, A; Gilardi, D; Furfaro, F; Danese, S
Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
2018-01-01 Bonovas, S; Pantavou, K; Evripidou, D; Bastiampillai, Aj; Nikolopoulos, Gk; Peyrin-Biroulet, L; Danese, S
Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?
2018-01-01 Pouillon, L; Van Stappen, J; Bossuyt, P; Danese, S; Peyrin-Biroulet, L
The biosimilar road in inflammatory bowel disease: The right way?
2014-01-01 Fiorino, G; Danese, S
The impact of biologics in surgical outcomes in ulcerative colitis
2018-01-01 Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S
The interaction between smoking, alcohol and the gut microbiome
2017-01-01 Capurso, Gabriele; Lahner, Edith
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Can IL-23 be a good target for ulcerative colitis? | 1-gen-2018 | Allocca, M; Furfaro, F; Fiorino, G; Gilardi, D; D'Alessio, S; Danese, S | |
| Colorectal cancer prevention in patients with ulcerative colitis | 1-gen-2018 | Lopez, A; Pouillon, L; Beaugerie, L; Danese, S; Peyrin-Biroulet, L | |
| Endoscopic ultrasound guided biliary interventions | 1-gen-2022 | Dell'Anna, Giuseppe; Ogura, Takeshi; Vanella, Giuseppe; Nishikawa, Hiroki; Lakhtakia, Sundeep; Arcidiacono, Paolo Giorgio | |
| Evolving strategies and goals of treatment in ulcerative colitis | 1-gen-2018 | Allocca, M; Peyrin-Biroulet, L; Danese, S | |
| Introduction | 1-gen-2022 | Arcidiacono, Paolo Giorgio; Santo, Erwin | |
| JAK inhibitors: Novel developments in management of ulcerative colitis | 1-gen-2018 | Fiorino, G; D'Amico, F; Italia, A; Gilardi, D; Furfaro, F; Danese, S | |
| Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses | 1-gen-2018 | Bonovas, S; Pantavou, K; Evripidou, D; Bastiampillai, Aj; Nikolopoulos, Gk; Peyrin-Biroulet, L; Danese, S | |
| Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis? | 1-gen-2018 | Pouillon, L; Van Stappen, J; Bossuyt, P; Danese, S; Peyrin-Biroulet, L | |
| The biosimilar road in inflammatory bowel disease: The right way? | 1-gen-2014 | Fiorino, G; Danese, S | |
| The impact of biologics in surgical outcomes in ulcerative colitis | 1-gen-2018 | Argollo, Mc; Kotze, Pg; Spinelli, A; Gomes, Tnf; Danese, S | |
| The interaction between smoking, alcohol and the gut microbiome | 1-gen-2017 | Capurso, Gabriele; Lahner, Edith |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile